Amisulpride and Rhabdomyolysis - a phase IV clinical study of FDA data


We study 5,845 people who have side effects when taking Amisulpride. Rhabdomyolysis is found, especially among people who are male, 60+ old, have been taking the drug for < 1 month, also take Diazepam and have Depression.

The phase IV clinical study analyzes which people take Amisulpride and have Rhabdomyolysis. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

On Sep, 25, 2023

5,845 people reported to have side effects when taking Amisulpride.
Among them, 106 people (1.81%) have Rhabdomyolysis.

What is Amisulpride?

Amisulpride has active ingredients of amisulpride. Currently, eHealthMe is studying from 5,869 Amisulpride users.

What is Rhabdomyolysis?

Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down) is found to be associated with 2,452 drugs and 1,898 conditions by eHealthMe. Currently, we are studying 59,050 people who have Rhabdomyolysis.

Number of Amisulpride and Rhabdomyolysis reports submitted per year:

Could Amisulpride cause Rhabdomyolysis?

Time on Amisulpride when people have Rhabdomyolysis *:

Click here to view

Gender of people who have Rhabdomyolysis when taking Amisulpride*:

Click here to view

Age of people who have Rhabdomyolysis when taking Amisulpride *:

Click here to view

Common drugs people take besides Amisulpride *:

Click here to view

Common side effects people have besides Rhabdomyolysis *:

Click here to view

Common conditions people have *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Amisulpride and have Rhabdomyolysis?

Check whether Rhabdomyolysis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Rhabdomyolysis and when was it recovered:

Expand to all the drugs that have ingredients of amisulpride:

Alternative drugs to, pros and cons of Amisulpride:

Browse all side effects of Amisulpride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Rhabdomyolysis treatments and more:

Common drugs associated with Rhabdomyolysis:

All the drugs that are associated with Rhabdomyolysis:

Common conditions associated with Rhabdomyolysis:

All the conditions that are associated with Rhabdomyolysis:

How the study uses the data?

The study uses data from the FDA. It is based on amisulpride (the active ingredients of Amisulpride) and Amisulpride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: